FIELD: medicine.
SUBSTANCE: method involves determining collagenase, collagenase inhibitor and protease inhibitor activity. Collagenase activity increasing to 4 mcmole/(l*h) and higher, protease inhibitor activity falling to 9 IU/ml and lower, collagenase inhibitor content falling to 1.9±0.2 IU/ml and lower, hepatic cirrhosis is to be diagnosed.
EFFECT: high accuracy and information capacity of the method.
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DIAGNOSING HEPATITIS TRANSIT INTO CHRONIC STAGE | 2005 |
|
RU2291440C1 |
METHOD FOR PREDICTING FIBROUS HEPATIC PROCESS AT CHRONIC VIRAL HEPATITIS | 2004 |
|
RU2270451C1 |
METHOD FOR DIFFERENTIAL DIAGNOSTICS OF CHRONIZATION STAGE OF CHRONIC VIRAL HEPATITIS OF TYPE B AND TYPE C | 2001 |
|
RU2193195C1 |
DIAGNOSTIC TECHNIQUE FOR CHRONIC VIRAL HEPATITIS TYPE C ASSOCIATED WITH OPIUM ADDICTION | 2010 |
|
RU2417370C1 |
METHOD FOR DIAGNOSING CHRONIC VIRAL B+C HEPATITIS ON THE OPISTORCHIASIS BACKGROUND | 2002 |
|
RU2226690C2 |
METHOD FOR PREDICTING CIRRHOSIS AT CHRONIC VIRAL HEPATITIS | 2003 |
|
RU2244306C1 |
METHOD OF DIFFERENTIAL DIAGNOSTICS OF HEPATIC FIBROSIS IN CASE OF CHRONIC VIRAL HEPATITIS C | 2009 |
|
RU2408289C1 |
METHOD OF ESTIMATION OF LIVER FIBROSIS DEGREE AT CHRONIC VIRUS HEPATITIS | 2007 |
|
RU2352950C1 |
DIAGNOSTIC TECHNIQUE FOR PRIMARY BILIARY CIRRHOSIS | 2009 |
|
RU2394498C1 |
METHOD FOR PREDICTING HEPATIC ENCEPHALOPATHY | 2006 |
|
RU2312599C1 |
Authors
Dates
2007-01-10—Published
2005-09-12—Filed